SEPT9 Test: Preliminary pivotal trial data

Preliminary data from the U.S. and German pivotal PRESEPT trial in 7,914 subjects showed that the SEPT9 Test had an overall cancer detection rate of 50%, with 91% specificity as measured on colonoscop...